Malawi Freedom Network 
By MFN News Desk Team
Published: 9 October 2026 | 05:06 AM CAT
Malawi’s Minister of Health and Sanitation, Madalitso Baloyi, has warned pharmaceutical suppliers that they risk a permanent ban from supplying the Central Medical Stores if they falsely declare medicine stocks to secure government contracts, as the government intensifies efforts to address drug shortages in public health facilities.
Baloyi said the ministry needs reliable pharmaceutical suppliers capable of delivering medicines that are physically available in their warehouses, rather than companies that win contracts by declaring stock they cannot immediately supply.
She stressed that transparency in pharmaceutical procurement is essential because delays in delivering medicines can undermine the delivery of healthcare services and put patients’ lives at risk.
“We do not want to wait any longer because we have lives that need to be saved. Any supplier that lies about their stock will be restricted from supplying the Central Medical Stores ever again,” Baloyi said.
Baloyi Demands Immediate Delivery of Medicines
The minister issued the warning during a meeting with Zunak Pharmaceuticals, where it emerged that some medicines included in the company’s contract were currently out of stock and were expected to arrive later in October.
The situation has highlighted the importance of verifying medicine availability before awarding or implementing supply contracts, particularly when public hospitals and health centres are experiencing shortages.
According to Baloyi, the ministry cannot afford procurement arrangements that leave essential medicines unavailable while suppliers wait for deliveries from their own sources.
She said pharmaceutical companies must provide accurate information about their available stocks to help the government make informed purchasing decisions and identify suppliers capable of meeting urgent medical needs.
The minister’s position signals a tougher approach to supplier accountability, with companies expected to demonstrate that the medicines they declare are genuinely available for delivery.
Zunak Pharmaceuticals to Submit Available Stock Data
Zunak Pharmaceuticals pharmacy manager Precious Chembezi said the company would compile information on medicines currently available at its Lilongwe and Mzuzu branches and submit the data to the Ministry of Health and Sanitation.
The information is expected to help the ministry identify medicines that can be supplied immediately, rather than waiting for products that are not currently available.
The proposed stock assessment could also help officials distinguish between medicines ready for delivery and those that remain dependent on future shipments.
However, the key issue will be whether the available medicines can be supplied quickly enough to help address shortages in public health facilities.
Drug Shortages Put Pressure on Public Healthcare
Medicine availability remains a critical concern for public healthcare delivery because patients depend on government facilities for treatment, including access to essential medicines.
When contracted suppliers cannot deliver medicines as expected, hospitals and health centres may struggle to meet patient needs. Procurement delays can also complicate planning for facilities that depend on regular supplies to provide uninterrupted services.
Baloyi’s warning places emphasis on the need for pharmaceutical suppliers to provide truthful stock information throughout the procurement process.
It also underscores the importance of matching government contracts with actual supply capacity, rather than relying solely on promises that medicines will become available at a later date.
For the ministry, the immediate priority is to secure medicines that can be delivered without unnecessary delays.
Permanent Ban Threat Raises Supplier Accountability Questions
The minister’s warning introduces a clear consequence for suppliers found misrepresenting their stock: exclusion from future supply opportunities through the Central Medical Stores.
Such a measure could strengthen accountability if declarations are properly verified and any restrictions are imposed through the applicable procurement procedures.
The announcement also raises broader questions about how medicine stocks are verified before contracts are awarded, how delivery commitments are monitored and what measures are taken when suppliers fail to meet their obligations.
Effective oversight would require accurate inventory records, clear delivery timelines and consistent checks to establish whether suppliers can fulfil their contractual commitments.
The ministry has not, in the information provided, announced that Zunak Pharmaceuticals has been found guilty of deliberately misrepresenting its stock or that a permanent ban has been imposed on the company. The meeting instead brought attention to medicines under contract that were currently unavailable and expected to arrive later in the month.
What Happens Next?
The immediate next step is for Zunak Pharmaceuticals to submit details of medicines available at its Lilongwe and Mzuzu branches to the ministry.
That information will help establish which products can be supplied immediately and which remain unavailable pending new deliveries.
The effectiveness of the ministry’s approach will ultimately depend on whether accurate stock declarations translate into faster deliveries and improved access to essential medicines at public health facilities.
For patients and healthcare workers, the central concern is straightforward: medicines must reach the facilities where they are needed, when they are needed.
Baloyi’s message to pharmaceutical suppliers is that the government expects honesty, reliability and the capacity to deliver. Companies that misrepresent their stock to secure contracts, she warned, risk losing the opportunity to supply the Central Medical Stores permanently.
Malawi Freedom Network will continue to follow developments in medicine procurement, pharmaceutical supply contracts and efforts to improve the availability of essential medicines in public health facilities.
